Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Debt Ratio (2023 - 2026)

Cannabis Bioscience International Holdings' Debt Ratio history spans 4 years, with the latest figure at 171.04 for Q1 2026.

  • On a quarterly basis, Debt Ratio rose 688.95% to 171.04 in Q1 2026 year-over-year; TTM through Feb 2026 was 171.04, a 688.95% increase, with the full-year FY2025 number at 8.28, up 89.9% from a year prior.
  • Debt Ratio hit 171.04 in Q1 2026 for Cannabis Bioscience International Holdings, up from 11.93 in the prior quarter.
  • Over the last five years, Debt Ratio for CBIH hit a ceiling of 171.04 in Q1 2026 and a floor of 2.57 in Q4 2023.
  • Historically, Debt Ratio has averaged 23.18 across 4 years, with a median of 7.6 in 2024.
  • Biggest five-year swings in Debt Ratio: decreased 28.34% in 2024 and later skyrocketed 694.13% in 2025.
  • Tracing CBIH's Debt Ratio over 4 years: stood at 2.57 in 2023, then soared by 195.75% to 7.6 in 2024, then soared by 57.09% to 11.93 in 2025, then skyrocketed by 1333.35% to 171.04 in 2026.
  • Business Quant data shows Debt Ratio for CBIH at 171.04 in Q1 2026, 11.93 in Q4 2025, and 13.17 in Q3 2025.